BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 25848532)

  • 1. Molecular alterations that drive breast cancer metastasis to bone.
    Ottewell PD; O'Donnell L; Holen I
    Bonekey Rep; 2015; 4():643. PubMed ID: 25848532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Regulation of Epithelial to Mesenchymal Transition in the Cancer Metastatic Cascade: Implications for Cancer Therapy.
    Liu QL; Luo M; Huang C; Chen HN; Zhou ZG
    Front Oncol; 2021; 11():657546. PubMed ID: 33996581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial plasticity, cancer stem cells and bone metastasis formation.
    van der Pluijm G
    Bone; 2011 Jan; 48(1):37-43. PubMed ID: 20670698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1β in breast cancer bone metastasis.
    Zhou J; Tulotta C; Ottewell PD
    Expert Rev Mol Med; 2022 Mar; 24():e11. PubMed ID: 35227338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of cells undergoing epithelial-mesenchymal transition to the tumour microenvironment.
    Mathias RA; Gopal SK; Simpson RJ
    J Proteomics; 2013 Jan; 78():545-57. PubMed ID: 23099347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer.
    Gunasinghe NP; Wells A; Thompson EW; Hugo HJ
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):469-78. PubMed ID: 22729277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
    Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Cell Colonisation in the Bone Microenvironment.
    Kan C; Vargas G; Pape FL; Clézardin P
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27782035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Carcinoma: From Initial Tumor Cell Detachment to Settlement at Secondary Sites.
    Melzer C; von der Ohe J; Hass R
    Biomed Res Int; 2017; 2017():8534371. PubMed ID: 28785589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel orthotopic model of breast cancer metastasis to bone.
    Lelekakis M; Moseley JM; Martin TJ; Hards D; Williams E; Ho P; Lowen D; Javni J; Miller FR; Slavin J; Anderson RL
    Clin Exp Metastasis; 1999 Mar; 17(2):163-70. PubMed ID: 10411109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour-derived miRNAs and bone metastasis.
    Croset M; Kan C; Clézardin P
    Bonekey Rep; 2015; 4():688. PubMed ID: 25987987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration in composition of keratin intermediate filaments in a model of breast cancer progression and the potential to reverse hallmarks of metastasis.
    Mackinder MA; Evans CA; Chowdry J; Staton CA; Corfe BM
    Cancer Biomark; 2012; 12(2):49-64. PubMed ID: 23396250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
    Garg M
    Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.
    Hamilton G; Rath B
    Adv Exp Med Biol; 2017; 994():229-245. PubMed ID: 28560677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells.
    Maenz C; Lenfert E; Pantel K; Schumacher U; Deppert W; Wegwitz F
    BMC Cancer; 2015 Mar; 15():178. PubMed ID: 25886487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into cancer metastasis from a clinicopathologic perspective: Epithelial-Mesenchymal Transition is not a necessary step.
    Chui MH
    Int J Cancer; 2013 Apr; 132(7):1487-95. PubMed ID: 22833228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
    Tan EJ; Olsson AK; Moustakas A
    Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-Mesenchymal Transition and Breast Cancer.
    Wu Y; Sarkissyan M; Vadgama JV
    J Clin Med; 2016 Jan; 5(2):. PubMed ID: 26821054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment.
    Demirkan B
    J Clin Med; 2013 Nov; 2(4):264-82. PubMed ID: 26237148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasis inhibition in breast cancer by targeting cancer cell extravasation.
    Cominetti MR; Altei WF; Selistre-de-Araujo HS
    Breast Cancer (Dove Med Press); 2019; 11():165-178. PubMed ID: 31114313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.